Previous studies have revealed that EGFR signaling restricts allergen-induced IL-6 production in an acute AD model [4], and EGFR acts as a negative regulator of TLR2 induction via p38 MAPK [18]. This evidence concerns the gene IL6 and Alzheimer disease.